Fn14 promotes myoblast fusion during regenerative myogenesis
Life Science Alliance · 2023-12 · 6 (12) · e202302312
DOI: 10.26508/lsa.202302312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 09.10.2023. Verfasst von Meiricris Tomaz da Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX, USA. Hauptthemen laut MEDLINE: Cell Communication, Myoblasts, TWEAK Receptor. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Skeletal muscle regeneration involves coordinated activation of an array of signaling pathways. Fibroblast growth factor–inducible 14 (Fn14) is a bona fide receptor for the TWEAK cytokine. Levels of Fn14 are increased in the skeletal muscle of mice after injury. However, the cell-autonomous role of Fn14 in muscle regeneration remains unknown. Here, we demonstrate that global deletion of the Fn14 receptor in mice attenuates muscle regeneration. Conditional ablation of Fn14 in myoblasts but not in differentiated myofibers of mice inhibits skeletal muscle regeneration. Fn14 promotes myoblast fusion without affecting the levels of myogenic regulatory factors in the regenerating muscle. Fn14 deletion in myoblasts hastens initial differentiation but impairs their fusion. The overexpression of Fn14 in myoblasts results in the formation of myotubes having an increased diameter after induction of differentiation. Ablation of Fn14 also reduces the levels of various components of canonical Wnt and calcium signaling both in vitro and in vivo. Forced activation of Wnt signaling rescues fusion defects in Fn14-deficient myoblast cultures. Collectively, our results demonstrate that Fn14-mediated signaling positively regulates myoblast fusion and skeletal muscle regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX, USA.
- Department of Biology and Biochemistry, University of Houston, Houston, TX, USA.
- Department of Pharmacological and Pharmaceutical Sciences, University of Houston College of Pharmacy, Houston, TX, USA akumar43@Central.UH.EDU.
ORCID-Profile: Meiricris Tomaz da Silva, Anirban Roy, Ashok Kumar
Förderung
- NIAMS NIH HHS
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Tomaz da Silva, M., Joshi, A. S., Castillo, M. B., Koike, T. E., Roy, A., Gunaratne, P. H., & Kumar, A. (2023). Fn14 promotes myoblast fusion during regenerative myogenesis. Life Science Alliance, 6(12), e202302312. https://doi.org/10.26508/lsa.202302312
Vancouver
Tomaz da Silva M, Joshi AS, Castillo MB, Koike TE, Roy A, Gunaratne PH, et al. Fn14 promotes myoblast fusion during regenerative myogenesis. Life Science Alliance. 2023;6(12):e202302312. doi:10.26508/lsa.202302312
BibTeX
@article{TomazdaSilva2023,
author = {Tomaz da Silva, Meiricris and Joshi, Aniket S and Castillo, Micah B and Koike, Tatiana E and Roy, Anirban and Gunaratne, Preethi H and Kumar, Ashok},
title = {Fn14 promotes myoblast fusion during regenerative myogenesis},
journal = {Life Science Alliance},
year = {2023},
volume = {6},
number = {12},
pages = {e202302312},
doi = {10.26508/lsa.202302312}
}
EUVIMED